Table-III.
Comparison of adverse reactions between the two groups [n (%)].
| Group | n | Adverse reactions | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Pain | Nausea and vomiting | Abdominal pain | Fever | Hepatic abscess | Hepatic rupture | Gastrointestinal hemorrhage | Liver dysfunction | Total | ||
| Control group | 64 | 1 (1.56) | 2 (3.13) | 1 (1.56) | 1 (3.13) | 1 (1.56) | 2 (3.13) | 1 (1.56) | 2 (3.13) | 11 (17.19) |
| Observation group | 61 | 0 (0) | 1 (1.64) | 0 (0) | 1 (1.64) | 0 (0) | 1 (1.64) | 0 (0) | 1 (1.56) | 3 (4.92) |
| χ2 | - | - | - | - | - | - | - | - | - | 4.727 |
| P | - | - | - | - | - | - | - | - | - | 0.030 |